Search hospitals > California > Los Angeles
UCLA CARE Center CRS
Claim this profileLos Angeles, California 90095
Global Leader in Human Immunodeficiency Virus Infection
Global Leader in Infections
Conducts research for AIDS
Conducts research for Contagious Diseases
Conducts research for HIV
181 reported clinical trials
3 medical researchers
Summary
UCLA CARE Center CRS is a medical facility located in Los Angeles, California. This center is recognized for care of Human Immunodeficiency Virus Infection, Infections, AIDS, Contagious Diseases, HIV and other specialties. UCLA CARE Center CRS is involved with conducting 181 clinical trials across 87 conditions. There are 3 research doctors associated with this hospital, such as Ronald Mitsuyasu, MD, Theodoros Kelesidis, MD PHD, and Raphael Landovitz, MD.Area of expertise
1Human Immunodeficiency Virus Infection
Global LeaderCD4⁺
CD8⁺
US
2Infections
Global LeaderTop PIs
Ronald Mitsuyasu, MDUCLA CARE Center8 years of reported clinical research
Studies Squamous Intraepithelial Lesion
Studies Cervical Intraepithelial Lesions
7 reported clinical trials
14 drugs studied
Theodoros Kelesidis, MD PHDUniversity of California Los Angeles2 years of reported clinical research
Studies AIDS
Studies Human Immunodeficiency Virus Infection
3 reported clinical trials
4 drugs studied
Raphael Landovitz, MDUCLA CARE Center CRS (601)3 years of reported clinical research
Studies Obesity
Studies Human Immunodeficiency Virus Infection
1 reported clinical trial
1 drug studied
Clinical Trials running at UCLA CARE Center CRS
Human Immunodeficiency Virus Infection
Lipid Disorders
Cardiovascular Risk
HIV
Metabolic Diseases
Obesity
Multiplex Polymerase Chain Reaction
HIV/AIDS
Doravirine
for HIV-Associated Weight Gain
This trial is testing if changing HIV medications to doravirine or switching drug combinations can help patients who have gained weight on their current treatment. The study focuses on people with HIV who have experienced significant weight gain. Doravirine works by blocking a different part of the virus, which might help reduce weight gain and improve overall health. Doravirine is an alternative treatment option for individuals who do not tolerate efavirenz.
Recruiting3 awards Phase 410 criteria
IL-15 Superagonist + Antibodies
for HIV/AIDS
The purpose of this study is to evaluate the safety, tolerability, and efficacy of N-803, an IL-15 superagonist, with or without combination broadly neutralizing antibodies (bNAbs), to induce HIV-1 control during analytic treatment interruption (ATI).
Recruiting1 award Phase 116 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at UCLA CARE Center CRS?
UCLA CARE Center CRS is a medical facility located in Los Angeles, California. This center is recognized for care of Human Immunodeficiency Virus Infection, Infections, AIDS, Contagious Diseases, HIV and other specialties. UCLA CARE Center CRS is involved with conducting 181 clinical trials across 87 conditions. There are 3 research doctors associated with this hospital, such as Ronald Mitsuyasu, MD, Theodoros Kelesidis, MD PHD, and Raphael Landovitz, MD.